Advertisement

Picture Eurasanté BioFIT 2017 Strasbourg France November 600x60px
Document › Details

Swedish Orphan Biovitrum AB. (10/6/17). "Press Release: Norbert Oppitz Joins Sobi as New Senior Vice President, Specialty Care".

Organisations Organisation Swedish Orphan Biovitrum AB (STO: SOBI)
  Group Swedish Orphan Biovitrum (Sobi) (Group)
  Organisation 2 Endo Pharmaceuticals (Group)
  Today Endo International (Group)
  Group Endo International (Group)
Product Product pharmaceutical
Person Person Oelkers, Guido (Swedish Orphan Biovitrum 201705– CEo before BSN Medical GmbH + Nycomed)
     


Swedish Orphan Biovitrum AB (publ) (Sobi™) today announces that Norbert Oppitz has been appointed Senior Vice President for the newly established business area Specialty Care.

Norbert Oppitz brings considerable management experience from over 30 years in the Pharmaceutical and Healthcare Industry. Most recently he has been a member of the Executive Committee of BSN Medical in charge of Latin America. Beforehand, he was a member of the Executive Committee of Endo Pharmaceuticals where he was in charge of emerging markets. In previous capacities, he has led large organisations as Head of Latin America at Takeda/Nycomed as well as in country management roles at Roche Pharmaceuticals and Aventis Pharma.

“We are delighted that Norbert could join Sobi. Norbert is a true entrepreneur, and his experience will be instrumental in realising our ambitions to bring Sobi to the next level as we look for external growth opportunities for our Specialty Care business,” says Guido Oelkers, President and CEO of Sobi.

Norbert Oppitz will head Sobi’s Specialty Care organisation and work closely together with Corporate Development and the regional and country organisations. Norbert will be part of Sobi’s Executive Leadership Team.

“I am excited to join Sobi – a company with a strong, patient-centric profile and a great potential. I look forward to contributing to the future growth of the company by realising a strategy to build and develop a strong and vital Specialty Care business unit,” says Norbert.

Norbert Oppitz joined Sobi on 2 October 2017.

_____


About Sobi™

Sobi™ is an international speciality healthcare company dedicated to rare diseases. Our mission is to develop and deliver innovative therapies and services to improve the lives of patients. The product portfolio is primarily focused on Haemophilia, Inflammation and Genetic diseases. We also market a portfolio of speciality and rare disease products across Europe, the Middle East, North Africa and Russia for partner companies. Sobi is a pioneer in biotechnology with world-class capabilities in protein biochemistry and biologics manufacturing. In 2016, Sobi had total revenues of SEK 5.2 billion (USD 608 M) and approximately 760 employees. The share (STO:SOBI) is listed on Nasdaq Stockholm. More information is available at www.sobi.com.


For more information please contact

Media relations
Linda Holmström, Senior Communications Manager
+46 70 873 40 95
linda.holmstrom@sobi.com

Investor relations
Jörgen Winroth, Vice President, Head of Investor Relations
+1 347 224 0819, +1 212 579 0506
jorgen.winroth@sobi.com

   
Record changed: 2017-10-06

Advertisement

Picture [LSF] Life-Sciences-France.com – The Business Web Portal 600x80px

More documents for Swedish Orphan Biovitrum (Sobi) (Group)


To subscribe to our free, monthly newsletter for the European life sciences, please send an e-mail to info@iito.de and simply fill the subject line with the word »LSE newsletter«

To get even more information, please take a look at our [gs] professional services offering and read the gene-sensor Product Flyer [PDF file]

Advertisement

Picture Eurasanté BioFIT 2017 Strasbourg France November 600x60px download




» top

Advertisements

Picture [iito] Twitter iitoLifeScience Life Sciences Mass Spec 120x120px Picture EBD Group Bio-Europe 2017 BEU Berlin Germany November 120x80px Picture Eurasanté BioFIT 2017 Strasbourg France November 120x80px Picture EBD Group Bio-Europe 2017 BEU Berlin Germany November 120x80px Picture [LSE] Life-Sciences-Europe.com – The Business Web Portal 120x600px Banner Fairtec GmbH Solutions for Smarter Business Events Exhibitions 120x120px Picture [iito] Twitter iitoLifeScience Life Sciences Mass Spec 120x120px Picture Eurasanté BioFIT 2017 Strasbourg France November 120x80px Picture EBD Group Bio-Europe 2017 BEU Berlin Germany November 120x80px